Barriers to green inhaler prescribing: ethical issues in environmentally sustainable clinical practice

The environmental impact of inhalers for asthma: A green challenge and a golden opportunity

(2021) Alex Wilkinson et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future

(2021) Marina Romanello et al.   LANCET

International comparison of health care carbon footprints

(2019) Peter-Paul Pichler et al.   Environmental Research Letters

Cost saving of switching to equivalent inhalers and its effect on health outcomes

(2019) Chloe I Bloom et al.   THORAX

Carbon footprint impact of the choice of inhalers for asthma and COPD

(2019) Christer Janson et al.   THORAX

Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England

(2019) Alexander J K Wilkinson et al.   BMJ Open

The Importance of Continuity in Inhaler Device Choice for Asthma and Chronic Obstructive Pulmonary Disease

(2014) Leif Bjermer   RESPIRATION

Retail sales of inhalation devices in European countries: So much for a global policy

(2011) F. Lavorini et al.   RESPIRATORY MEDICINE

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control

(2009) Mike Thomas et al.   BMC Pulmonary Medicine